Released Aug 7, 2015, after the close
10-Q filed Aug 7, 2015, 38 days after period end · 0001104659-15-057722
Q2 2015 · 10-Q
Revenue$27.74M$27.74M +305.6% vs Q2 2014−4.1% vs Q1 2015
Net income—
EPS Diluted-$0.34-$0.34 N/M vs Q2 2014N/M vs Q1 2015
Operating Income-$42,009,000N/M
Operating Cash Flowderived-$25,554,000N/M
Free Cash Flowderived-$26,407,000N/M
Margins · derived
Operating margin-151.4%+654.4 pt vs Q2 2014
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Revenue | $27.74M | $6.84M | $9.66M | $14.60M |
| EPS Diluted | -$0.34 | -$0.44 | -$0.57 | -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR